Nav: Home

Infection-fighting protein also senses protein misfolding in non-infected cells

July 08, 2019

Researchers at the University of Toronto have uncovered an immune mechanism by which host cells combat bacterial infection, and at the same time found that a protein crucial to that process can sense and respond to misfolded proteins in all mammalian cells.

The protein is called heme-regulated inhibitor or HRI, and the researchers showed that during bacterial infection it triggers and coordinates a chain reaction among other proteins that form a larger complex. That larger group or 'signalosome' amplifies inflammation and leads to an anti-bacterial response.

But HRI can also regulate protein folding in other cell types, the researchers showed. Protein folding, which helps determine the 3-D shape of a protein and is essential for its function, is implicated in non-infectious diseases including the neurodegenerative disorders Parkinson's, Alzheimer's and ALS.

"The innate immune function that we discovered is essentially a mechanism of protein scaffolding, which is important because you want a quick and orderly response to bacterial infection," says Stephen Girardin, a professor of laboratory medicine and pathobiology and of immunology at U of T. "But we also found that same pathway is important for protein scaffolding and aggregation in other cells, which opens promising research angles for neurodegenerative and other diseases."

The journal Science published the findings today.

Researchers have studied HRI for over three decades, but mostly in the context of red blood cell disorders. "This protein appears in all cells in the mammalian body and was recognized as a broad or promiscuous sensor," says Mena Abdel-Nour, lead author on the paper who completed his doctorate in Girardin's lab earlier this year. "But it was overlooked relative to pattern recognition molecules and the formation of amyloid-like structures. We had to test its role in several different pathways before we believed what we saw."

Abdel-Nour and his colleagues developed a novel technique to study the effects of HRI. They adapted a biochemistry assay from the lab of Jeffrey Lee -- a professor of laboratory medicine and pathobiology at U of T whose team works beside their own -- which helped them distinguish between folded and misfolded proteins when looking at protein aggregates. Scientists have struggled to make that distinction in part because most available tests only work in test tubes and are not adaptable to cells.

The researchers have early pre-clinical data that shows HRI could protect against the type of neurodegeneration seen in Parkinson's. "Speculatively, it might be possible to find molecules that produce HRI's protective effects, which could lead to a bona fide therapy," says Abdel-Nour, who plans to pursue a career as a biotechnology and health-care consultant. Current therapies for Parkinson's focus on finding and clearing out protein aggregates, rather than fixing cellular defects before those clusters accumulate.

Girardin says he is committed to pursuing that research in collaboration with neuroscientists, and he just received funding to support that work. "We are focused on Parkinson's because it's a very important disease for human health, and because its hallmark is protein aggregation inside cells, so it may be a perfect model to test this new pathway."

Next steps include biochemical investigations of HRI and related complexes during protein misfolding, and animal studies of neurodegenerative disease to further validate the new pathway, which shares many features with a similar pathway in humans.
-end-
Several researchers collaborated on the study including Dana Philpott, a professor of immunology at U of T, and Damien Arnoult, a professor at INSERM, France's national institute of health and medical research.

University of Toronto

Related Proteins Articles:

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.
Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.
Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.
Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.
Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.
Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.
Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.
How proteins become embedded in a cell membrane
Many proteins with important biological functions are embedded in a biomembrane in the cells of humans and other living organisms.
Finding the proteins that unpack DNA
A new method allows researchers to systematically identify specialized proteins called 'nuclesome displacing factors' that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
A brewer's tale of proteins and beer
The transformation of barley grains into beer is an old story, typically starring water, yeast and hops.
More Proteins News and Proteins Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.